UTA FAMILY 3 FINAL EXAM QUESTIONS
AND ANSWERS 2026
2017 ACC/AHA guidelines: normal BP - ANSWERS<120 / <80
2017 ACC/AHA guidelines: elevated BP - ANSWERS120-129/ <80
2017 ACC/AHA guidelines: stage 1 HTN - ANSWERS130--89
2017 ACC/AHA guidelines: stage 2 HTN - ANSWERS≥ 140/ ≥ 90
What is recommended for white coat hypertension? - ANSWERS- lifestyle modification
- annual ABPM or HBPM
What is recommended for masked hypertension? - ANSWERS- lifestyle modification
- start HTN medication
What is recommended for elevated BP? - ANSWERS- lifestyle modification
- annual ABPM
What is secondary hypertension? - ANSWERS- drug resistant/induced hypertension
- exacerbation of previously controlled hypertension
- accelerated/malignant hypertension
- unprovoked or excessive hypokalemia
What are common causes of secondary hypertension? - ANSWERS- renal disease
- aldosteronism
- OSA
- drug and alcohol induced
What are non-pharmacological interventions for hypertension? - ANSWERS- weight
loss
- DASH diet
- sodium reduction
- potassium supplementation
- reduce alcohol consumption
2017 ACC/AHA guidelines: clinical CVD and BP ≥ 130 / ≥ 80 - ANSWERSuse BP
lowering meds
2017 ACC/AHA guidelines: primary prevention in adults 10 yr ASCVD risk of ≥ 10% -
ANSWERSuse BP lowering meds
, 2017 ACC/AHA guidelines: 10 yr risk < 10% and SBP ≥ 140/90 - ANSWERSuse BP
lowering meds
2017 ACC/AHA guidelines: normal BP reassessment - ANSWERSyearly
2017 ACC/AHA guidelines: elevated BP reassessment - ANSWERS3-6 months
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD < 10% -
ANSWERS3-6 months
2017 ACC/AHA guidelines: stage 2 HTN reassessment - ANSWERSone month until
goal BP met, then 3-6 months
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD > 10% -
ANSWERSone month until BP goal met, then 3-6 months
What hypertensive medications should not be prescribed simultaneously? - ANSWERS-
ACE
- ARB
- Renin Inhibitor
2017 ACC/AHA guidelines: first line agents - ANSWERS- thiazide diuretics
- CCBs
- ACE
- ARBs
2017 ACC/AHA guidelines: initiation of drug therapy in stage 2 HTN - ANSWERSinitiate
drug therapy with 2 first line medications of different classes as separate agents or
combo drug
2017 ACC/AHA guidelines: initiation of drug therapy in stage 1 HTN - ANSWERSinitiate
therapy with a single drug
2017 ACC/AHA guidelines: HTN reassessment for new or adjusted drug regimen -
ANSWERSfollow up at monthly intervals until control is sustained
2017 ACC/AHA guidelines: black adults with HTN, no HF or CKD - ANSWERSinitiate
therapy with thiazide diuretic or CCB
2017 ACC/AHA guidelines: pregnant or planning pregnancy safe drug choice -
ANSWERS- methyldopa
- nifedipine
- labetalol
2017 ACC/AHA guidelines: drugs contraindicated in pregnant women - ANSWERS-
ACE
AND ANSWERS 2026
2017 ACC/AHA guidelines: normal BP - ANSWERS<120 / <80
2017 ACC/AHA guidelines: elevated BP - ANSWERS120-129/ <80
2017 ACC/AHA guidelines: stage 1 HTN - ANSWERS130--89
2017 ACC/AHA guidelines: stage 2 HTN - ANSWERS≥ 140/ ≥ 90
What is recommended for white coat hypertension? - ANSWERS- lifestyle modification
- annual ABPM or HBPM
What is recommended for masked hypertension? - ANSWERS- lifestyle modification
- start HTN medication
What is recommended for elevated BP? - ANSWERS- lifestyle modification
- annual ABPM
What is secondary hypertension? - ANSWERS- drug resistant/induced hypertension
- exacerbation of previously controlled hypertension
- accelerated/malignant hypertension
- unprovoked or excessive hypokalemia
What are common causes of secondary hypertension? - ANSWERS- renal disease
- aldosteronism
- OSA
- drug and alcohol induced
What are non-pharmacological interventions for hypertension? - ANSWERS- weight
loss
- DASH diet
- sodium reduction
- potassium supplementation
- reduce alcohol consumption
2017 ACC/AHA guidelines: clinical CVD and BP ≥ 130 / ≥ 80 - ANSWERSuse BP
lowering meds
2017 ACC/AHA guidelines: primary prevention in adults 10 yr ASCVD risk of ≥ 10% -
ANSWERSuse BP lowering meds
, 2017 ACC/AHA guidelines: 10 yr risk < 10% and SBP ≥ 140/90 - ANSWERSuse BP
lowering meds
2017 ACC/AHA guidelines: normal BP reassessment - ANSWERSyearly
2017 ACC/AHA guidelines: elevated BP reassessment - ANSWERS3-6 months
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD < 10% -
ANSWERS3-6 months
2017 ACC/AHA guidelines: stage 2 HTN reassessment - ANSWERSone month until
goal BP met, then 3-6 months
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD > 10% -
ANSWERSone month until BP goal met, then 3-6 months
What hypertensive medications should not be prescribed simultaneously? - ANSWERS-
ACE
- ARB
- Renin Inhibitor
2017 ACC/AHA guidelines: first line agents - ANSWERS- thiazide diuretics
- CCBs
- ACE
- ARBs
2017 ACC/AHA guidelines: initiation of drug therapy in stage 2 HTN - ANSWERSinitiate
drug therapy with 2 first line medications of different classes as separate agents or
combo drug
2017 ACC/AHA guidelines: initiation of drug therapy in stage 1 HTN - ANSWERSinitiate
therapy with a single drug
2017 ACC/AHA guidelines: HTN reassessment for new or adjusted drug regimen -
ANSWERSfollow up at monthly intervals until control is sustained
2017 ACC/AHA guidelines: black adults with HTN, no HF or CKD - ANSWERSinitiate
therapy with thiazide diuretic or CCB
2017 ACC/AHA guidelines: pregnant or planning pregnancy safe drug choice -
ANSWERS- methyldopa
- nifedipine
- labetalol
2017 ACC/AHA guidelines: drugs contraindicated in pregnant women - ANSWERS-
ACE
